Zobrazeno 1 - 10 of 19 pro vyhledávání: '"Aviv Pudipeddi"'
1
Akademický článek
Comparing persistence of new biologics to conventional anti-TNF alphas in adult patients with inflammatory bowel disease: a systematic review and meta-analysis protocol
Autor: Rupert W Leong, Yanna Ko, Patrizia Natale, Aviv Pudipeddi, Tsz Hong Yiu
Publikováno v: BMJ Open, Vol 13, Iss 10 (2023)
Background Biological therapy is a cornerstone of managing moderate-to-severe inflammatory bowel disease (IBD), ulcerative colitis (UC) and Crohn’s disease (CD). New biologics have been evolving over the past 20 years and selection of an agent rema
Externí odkaz: https://doaj.org/article/bd019cde00bd4204969e160e085a130e
Zobrazit plný text záznamu
2
Akademický článek
Vedolizumab has longer persistence than infliximab as a first-line biological agent but not as a second-line biological agent in moderate-to-severe ulcerative colitis: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study
Autor: Aviv Pudipeddi, Yanna Ko, Sudarshan Paramsothy, Rupert W. Leong
Publikováno v: Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: The choice between infliximab (IFX) and vedolizumab (VED) as a first-line biological agent in moderate-to-severe ulcerative colitis (UC) can be difficult. Second-line vedolizumab (VED) efficacy may decline following prior infliximab (IFX)
Externí odkaz: https://doaj.org/article/4b864aef8e674dc794848a9969190187
Zobrazit plný text záznamu
4
Tryptophan Metabolism ‘Hub’ Gene Expression Associates with Increased Inflammation and Severe Disease Outcomes in COVID-19 Infection and Inflammatory Bowel Disease
Autor: Sonia Bustamante, Yunki Yau, Victoria Boys, Jeff Chang, Sudarshan Paramsothy, Aviv Pudipeddi, Rupert W. Leong, Valerie C. Wasinger
Publikováno v: International Journal of Molecular Sciences; Volume 23; Issue 23; Pages: 14776
The epithelial barrier’s primary role is to protect against entry of foreign and pathogenic elements. Both COVID-19 and Inflammatory Bowel Disease (IBD) show commonalities in symptoms and treatment with sensitization of the epithelial barrier invit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f25e8186046b3b0e0b056b3579b97f0
Zobrazit plný text záznamu
8
High prevalence of Crohn disease and ulcerative colitis among older people in Sydney
Autor: Charles McDonald, John Napoli, Thomas J. Borody, Rupert W. Leong, Webber Chan, Peter H. Katelaris, Anil Keshava, Daniel A. Lemberg, Aviv Pudipeddi, Sudarshan Paramsothy, Viraj C. Kariyawasam, Crispin Corte, Robert Clancy, Cheng H Lee, Grace Chapman, Jeffrey Liu, James L. Cowlishaw
Publikováno v: Medical Journal of Australia. 214:365-370
Objectives To determine the age-standardised prevalence of inflammatory bowel disease (IBD) in a metropolitan area of Sydney, with a focus on its prevalence among older people. Design, setting Population-based epidemiological study of people with IBD
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1280e6bd6067735d41f88b9f26c10169
https://doi.org/10.5694/mja2.50910
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje